Literature DB >> 30023303

Vaccination triggering onset of m.8993T > G associated Leigh syndrome.

Josef Finsterer1, Sinda Zarrouk-Mahjoub2.   

Abstract

Entities:  

Keywords:  Lactate; Mitochondrial; Multisystem disease; Mutation; Renal; mtDNA

Year:  2018        PMID: 30023303      PMCID: PMC6047472          DOI: 10.1016/j.ymgmr.2018.04.001

Source DB:  PubMed          Journal:  Mol Genet Metab Rep        ISSN: 2214-4269


× No keyword cloud information.
Letter to the Editor. We read with interest the article by Uittenbogaard et al. about a 2yo male with maternally-inherited Leigh syndrome (MILS) due to the ATP6 variant m.8993T > G at a heteroplasmy rate of 83% [1]. We have the following comments and concerns. Normal development of the infant was interrupted by a vaccination with various vaccines at age 4 m [1]. Did the patient undergo CSF investigations after having developed floppy infant syndrome and was meningitis excluded? Why did the patient receive a second set of vaccines at age 6 m resulting in the inability of breastfeeding after the previous adverse reaction [1]? Fig. 1 shows a significant increase of the size of the ventricles between age 4 m and age 9 m, suggesting hydrocephalus [1]. Cortical atrophy does not explain the dramatic dynamics, why it should be mentioned if the CSF pressure was increased and if the patient received a ventriculo-peritoneal shunt. Infantile spasms (West syndrome) were treated with a combination of three antiepileptic drugs (AEDs) [1]. This unusual combination was obviously ineffective [1]. In a recent systemic review it has been shown that ketogenic diet may be beneficial in infantile spasms. Was ketogenic diet tried in the index case as well and was it beneficial? In addition to ketogenic diet and topiramat, West syndrome may respond to ACTH, steroids, and vigabatrim [2]. Were any of these alternative AEDs applied? In a study of 40 patients with infantile spasms, topiramat and levetiracetam were ineffective [3]. The variant m.8993T > G may not only manifest in the brain but also in the muscles [4], peripheral nerves (neuropathy), kidneys, or the eyes (retinitis pigmentosa, macular degeneration) [5]. Another feature may be hypocitrullinemia. Were any of these phenotypic features detected in the index case? In summary, additional data about the cause of hydrocephalus, the treatment of epilepsy, and the phenotypic spectrum are eligible.

Conflict of interest

There are no conflicts of interest.

Funding

No funding was received.

Author contribution

JF: design, literature search, discussion, first draft, SZ-M: literature search, discussion, critical comments.
  5 in total

Review 1.  Efficacy of Treatments for Infantile Spasms: A Systematic Review.

Authors:  Ji Min Song; Jongsung Hahn; Se Hee Kim; Min Jung Chang
Journal:  Clin Neuropharmacol       Date:  2017 Mar/Apr       Impact factor: 1.592

2.  Ineffectiveness of topiramate and levetiracetam in infantile spasms non-responsive to steroids. Open labeled randomized prospective study.

Authors:  Adel A Mahmoud; Tamer M Rizk; Ahmed A Mansy; Jaffar A Ali; Mohamad A Al-Tannir
Journal:  Neurosciences (Riyadh)       Date:  2013-04       Impact factor: 0.906

3.  Leigh-Like Syndrome Due to Homoplasmic m.8993T>G Variant with Hypocitrullinemia and Unusual Biochemical Features Suggestive of Multiple Carboxylase Deficiency (MCD).

Authors:  Shanti Balasubramaniam; B Lewis; D M Mock; H M Said; M Tarailo-Graovac; A Mattman; C D van Karnebeek; D R Thorburn; R J Rodenburg; J Christodoulou
Journal:  JIMD Rep       Date:  2016-07-22

4.  Novel insights into the functional metabolic impact of an apparent de novo m.8993T>G variant in the MT-ATP6 gene associated with maternally inherited form of Leigh Syndrome.

Authors:  Martine Uittenbogaard; Christine A Brantner; ZiShui Fang; Lee-Jun C Wong; Andrea Gropman; Anne Chiaramello
Journal:  Mol Genet Metab       Date:  2018-03-27       Impact factor: 4.797

5.  Phenotype-genotype correlations in Leigh syndrome: new insights from a multicentre study of 96 patients.

Authors:  Kalliopi Sofou; Irenaeus F M de Coo; Elsebet Ostergaard; Pirjo Isohanni; Karin Naess; Linda De Meirleir; Charalampos Tzoulis; Johanna Uusimaa; Tuula Lönnqvist; Laurence Albert Bindoff; Már Tulinius; Niklas Darin
Journal:  J Med Genet       Date:  2017-11-03       Impact factor: 6.318

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.